Dr. Brian Thomas Halbert, MD

Dr. Halbert practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System.

Dr. Halbert's NPI, 1003109364, was assigned on May 19, 2011. Dr. Halbert graduated from Tulane University School of Medicine in 2011. Dr. Halbert holds Louisiana license 331370.

Dr. Halbert's primary practice is Ochsner Medical Center - New Orleans, at 1516 Jefferson Hwy, New Orleans, LA 70121 in Jefferson Parish. The practice phone is (504) 842-3000.

Dr. Halbert's primary practice is Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System. Dr. Halbert is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Ochsner Health. Dmand AI also links Dr. Halbert to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Halbert practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Halbert's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Halbert is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Halbert's licenses on file in 2 states: Louisiana and Massachusetts.

CMS data shows 707 Medicare services from Dr. Halbert across 5 procedure codes in 2024, for 146 Medicare patients. Medicare paid $50,982 for them.

CMS counts 146 Medicare patients who saw Dr. Halbert in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have cancer, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Halbert's median patient age at 74, with 14% women.

In 2024, Dr. Halbert wrote 2,208 Medicare Part D claims for 257 patients. 78% of them were for generic drugs. CMS names the drug for 1,917 of them, across 47 drugs with 11 or more claims each, at $4,977,737 in total drug cost. In 2023, CMS named 1,492 claims across 41 drugs.

Dr. Halbert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Halbert as offering telehealth.

Dmand AI links 7 papers to Dr. Halbert, published from 2016 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Carcinoma, Renal Cell and Kidney Neoplasms. Dr. Halbert's most frequent co-authors are David Chiu, MD, David Chiu, MD and Daniel Botelho Costa, MD.

CMS Open Payments shows 58 general payments to Dr. Halbert from 13 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 68% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,989.

Dr. Halbert graduated from Tulane University School of Medicine in 2011.